Quadrivalent inactivated subunit adjuvanted influenza vaccine - Jiangsu Zhonghui Yuantong Biotechnology
Latest Information Update: 22 Nov 2023
At a glance
- Originator Jiangsu Zhonghui Yuantong Biotechnology
- Class Influenza virus vaccines; Subunit vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preregistration Influenza virus infections
Most Recent Events
- 13 Oct 2023 Ab&b Biotechnology completes a phase III trial in Influenza virus infections prevention (In children, In infants) in China (IM) (NCT05645900)
- 06 Feb 2023 Phase-III clinical trials in Influenza virus infections prevention (In children, In infants) in China (IM) (NCT05645900)
- 01 Dec 2022 Jiangsu Zhonghui Yuantong Biotechnology plans a phase III trial for Influenza virus infections prevention (In infants, In children) in China (IM) (NCT05645900)